Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the efficacy, safety and tolerability of AD 237 in patients with chronic obstructive pulmonary disease (COPD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sosei
Collaborators
NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07383896 · Asthma, COPD
NCT07112235 · COPD (Chronic Obstructive Pulmonary Disease), Rhinovirus Infection, and more
NCT07518472 · Pulmonary Disease, Chronic Obstructive (COPD)
Specialized Hospital for Active Treatment Pneumophthysiatric Disease "Kudoglu"
Plovdiv
Regional Dispensary for Pulmonary Diseases Rousse
Rousse
5-th Multiprofile Hospital for Active Treatment
Sofia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions